Medication Adherence Telemonitoring to Reduce Heart Failure Readmissions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Heart Failure
Interventions
BEHAVIORAL

Medication adherence telemonitoring

The member of the study team will respond to adherence data using clinical judgment as they would if the information was obtained during clinical care. Specifically, when contacting nonadherent participants, the member of the study team will provide participants with feedback on their electronic adherence; will inquire about potential consequences of missed doses; and will assess and respond to reasons for missed doses.

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

New York Presbyterian Hospital

OTHER

lead

Columbia University

OTHER

NCT02378571 - Medication Adherence Telemonitoring to Reduce Heart Failure Readmissions | Biotech Hunter | Biotech Hunter